0,082€
27,34%
Echtzeit-Aktienkurs Genetic Technologies Ltd.
Bid:
Ask:
Echtzeit-Chart der Genetic Technologies Ltd. Aktie
Börsenkurse Genetic Technologies Ltd.
Echtzeit Euro | - | - | - | - | 0,082€ | 27,34% |
Börse Stuttgart | - | - | - | - | 0,082€ | -13,68% |
Profil der Genetic Technologies Ltd. Aktie
Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment focuses on AffinityDNA branded test sales and expenses.The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.